Call for Abstracts of Free Paper

Call for Abstracts

Call for Abstracts for International Session in the JSPRS2023 Annual Meeting and the APRAS Meeting will be open from November 30 (Wed.), 2022 until noon on January 10 (Tue.), 2023 (JST).

Important Date

Deadline for Abstract Submission

January 10 (Tue.), 2023, at noon (JST)

Notification of Acceptance (by E-mail)

Notification will be sent by early February 2023 by E-mail.

Type of Presentation

Each speaker will have 8 minutes for presentation. Please time your talk for 6 minutes, and 2 minutes for questions and answers. *Subject to change

※Type of presentation in the JSPRS2023 is only ORAL PRESENTATION.

Abstract Submission Guidelines

Your abstract must include:

• Your Name (Name of the First Author)
• Name(s) of Affiliation (This will be printed in the Program Book)
• Name(s) and Affiliation(s) for Co-Authors (up to 8 people)
• Contact E-mail Address
• Title of Abstract (within 15 words)
  The abstract title should be brief and clearly indicate the nature of the presentation. Do not put a period at the end of the title.
• Abstract Body (within 250 words)
  The entire body of the abstract must not exceed 250 words.
  Spaces are not included in this number. No tables or diagrams should be included.
• Category
  Please select 1 or 2 Categories to your abstract. (Categories will not be printed in the Program Book; they will be used as a reference for peer review.)

Category

Abstract Review and Selection Process

• After the submission deadline, all completed and eligible abstracts will be made available to the Organizing Review Committees for blinded review and scoring, and final decisions will be made in the end of January 2023.
• Incomplete abstracts will not be reviewed.
• All abstracts submitted will be considered eligible for one presentation (ORAL PRESENTATION).

Acceptance / Rejection Notification

• Notification regarding acceptance or rejection of abstracts will be sent to the first (presenting) author by early February  by e-mail; consequently, an accurate e-mail address is critical. Rejection notifications will also be sent at that time.
• If you have not received the e-mail, please contact Congress Secretariat shown at the bottom of this page.

Conflict-of-Interest (COI) Disclosure Policies

• Conflict-of-Interest (COI) Policy requires disclosure of any financial or other interest that might be construed as resulting in an actual, potential, or apparent conflict.
• Please disclose any relationships or circumstances that might affect or appear to affect the research presented. These relationships include you or any individual with whom you directly share income.
• All authors and co-authors are required to provide any relevant information concerning personal or professional circumstances and relationships that might reasonably be expected to affect the author's view on the presentation; including relationships with pharmaceutical companies, or other companies whose products or services are related to the subject matter of the presentation topic. If no relevant relationships exist, this must be stated as well.

Abstract Submission

All abstracts should be submitted through the online abstract submission system.

Abstract Submission closed.

Inquiries for Abstract Submission

Congress Secretariat
c/o Congrès Inc.
Phone: +81-92-716-7116　Fax: +81-92-716-7143
E-mail: jsprs66-ab@congre.co.jp